V006-1721 Screening compound: 2-({[(2H-1,3-benzodioxol-5-yl)methyl](3,3-diphenylpropyl)amino}methyl)-N-(2-phenylethyl)-1,3-thiazole-4-carboxamide

V006-1721 Screening compound: 2-({[(2H-1,3-benzodioxol-5-yl)methyl](3,3-diphenylpropyl)amino}methyl)-N-(2-phenylethyl)-1,3-thiazole-4-carboxamide
V006-1721 Screening compound: 2-({[(2H-1,3-benzodioxol-5-yl)methyl](3,3-diphenylpropyl)amino}methyl)-N-(2-phenylethyl)-1,3-thiazole-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V006-1721
2-({[(2H-1,3-benzodioxol-5-yl)methyl](3,3-diphenylpropyl)amino}methyl)-N-(2-phenylethyl)-1,3-thiazole-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V006-1721

Molecular Formula

C36H35N3O3S (C36 H35 N3 O3 S)

Compound Name

2-({[(2H-1,3-benzodioxol-5-yl)methyl](3,3-diphenylpropyl)amino}methyl)-N-(2-phenylethyl)-1,3-thiazole-4-carboxamide

IUPAC name

2-({[(2H-13-benzodioxol-5-yl)methyl](33-diphenylpropyl)amino}methyl)-N-(2-phenylethyl)-13-thiazole-4-carboxamide

SMILES

O=C(c1csc(CN(CCC(c2ccccc2)c2ccccc2)Cc(cc2)cc3c2OCO3)n1)NCCc1ccccc1

InChI

InChI=1S/C36H35N3O3S/c40-36(37-20-18-27-10-4-1-5-11-27)32-25-43-35(38-32)24-39(23-28-16-17-33-34(22-28)42-26-41-33)21-19-31(29-12-6-2-7-13-29)30-14-8-3-9-15-30/h1-17,22,25,31H,18-21,23-24,26H2,(H,37,40)

InChI Key

JVACITCMMVPHBT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19771365

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

589.76

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

14.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

6.926

Distribution Coefficient, logD

6.925

Water Solubility, LogSw

-6.09

Polar Surface Area

55.256

Acid Dissociation Constant (pKa)

13.86

Base Dissociation Constant (pKb)

4.89

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

22.20

V006-1721 in Drug Discovery

Included in Screening Libraries

DGK Inhibitors Library (10558 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V006-1721 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V006-1721?
Check Price and Availability of V006-1721, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V006-1721 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V006-1721
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V006-1721
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V006-1721 available by request